CCM
PFE icon

Cox Capital Management’s Pfizer PFE Stock Holding History

Cox Capital Management’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-66,982
Closed -$1.86M – 77
2024
Q1 		$1.86M Buy
66,982
+21,147
+46% +$587K 1.15% 38
2023
Q4 		$1.32M Sell
45,835
-23,478
-34% -$710K 0.86% 45
2023
Q3 		$2.3M Buy
69,313
+6,824
+11% +$241K 1.62% 28
2023
Q2 		$2.29M Sell
62,489
-1,049
-2% -$40.8K 1.69% 26
2023
Q1 		$2.59M Buy
63,538
+84
+0.1% +$3.63K 1.87% 24
2022
Q4 		$3.25M Sell
63,454
-809
-1% -$38.8K 2.12% 12
2022
Q3 		$2.81M Buy
64,263
+3,329
+5% +$162K 2.04% 16
2022
Q2 		$3.19M Sell
60,934
-30
-0% -$1.53K 2.18% 11
2022
Q1 		$3.16M Sell
60,964
-717
-1% -$37.2K 1.99% 17
2021
Q4 		$3.64M Sell
61,681
-825
-1% -$40.9K 2.15% 12
2021
Q3 		$2.69M Buy
62,506
+2,192
+4% +$97.1K 1.81% 23
2021
Q2 		$2.36M Buy
60,314
+2,379
+4% +$92.5K 1.58% 24
2021
Q1 		$2.1M Buy
57,935
+293
+0.5% +$10.4K 1.45% 29
2020
Q4 		$2.12M Sell
57,642
-376
-0.6% -$13.8K 1.62% 21
2020
Q3 		$2.02M Buy
58,018
+895
+2% +$31.4K 1.78% 16
2020
Q2 		$1.77M Buy
57,123
+2,249
+4% +$76.4K 1.75% 20
2020
Q1 		$2.04M Hold
54,874
– – 1.78% 21
2019
Q4 		$2.04M Buy
54,874
+955
+2% +$34K 1.86% 21
2019
Q3 		$1.84M Buy
53,919
+13,882
+35% +$505K 1.79% 22
2019
Q2 		$1.65M Buy
40,037
+595
+2% +$23.6K 1.67% 25
2019
Q1 		$1.59M Buy
39,442
+556
+1% +$22.3K 1.72% 25
2018
Q4 		$1.51M Buy
38,886
+719
+2% +$29.8K 1.77% 25
2018
Q3 		$1.6M Buy
38,167
+513
+1% +$19.7K 1.7% 25
2018
Q2 		$1.3M Buy
+37,654
New +$1.29M 1.56% 35

Other funds holding PFE

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Cox Capital Management's PFE Position: Q2 2024 in Review

Cox Capital Management sold out of Pfizer (PFE) in Q2 2024, closing a stake of 66,982 shares — an estimated $1.86M sold.

Cox Capital Management first reported a position in PFE in Q2 2018 and held it in 24 quarters. The position peaked at $3.64M in Q4 2021. 2,873 funds tracked by Wall St. Rank hold PFE as of Q2 2024.

  • Cox Capital Management reported no remaining Pfizer position as of Q2 2024 after selling out during the quarter.
  • Cox Capital Management sold 66,982 Pfizer shares in Q2 2024, an estimated $1.86M.
  • Cox Capital Management first reported a position in Pfizer in Q2 2018 and held it in 24 quarters.
  • Cox Capital Management's Pfizer position peaked at $3.64M in Q4 2021.
  • 2,873 funds tracked by Wall St. Rank held Pfizer as of Q2 2024.

Based on Cox Capital Management's 13F filing for Q2 2024, filed 16 Jul 2024.